Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Squamous Cell Carcinoma × obinutuzumab × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 24 Lymphoma, Follicular 15 Lymphoma, Non-Hodgkin 9 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma, Mantle-Cell 5 Lymphoma 5 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia 3 Neoplasms 2 Bronchiolitis Obliterans Syndrome 2 Tumor Lysis Syndrome 1 Solid Tumors 1 Recurrence 1 Oncology Patients Receiving Chemotherapy 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Leukemia, Prolymphocytic, B-Cell 1 Leukemia, Lymphoid 1 Leukemia, Hairy Cell 1 Indolent Non-Hodgkin's Lymphoma 1 Chromosome 17 deletion 1 Carcinoma, Non-Small-Cell Lung 1 B-cell Malignancies 1 Anemia 1

Interventions

Radiotherapy 10 Cisplatin 9 Paclitaxel 8 pembrolizumab 7 Fluorouracil 7 Oxaliplatin 6 Irinotecan 6 Cetuximab 5 tislelizumab 4 Docetaxel 4 Radiation 3 Leucovorin 3 Carboplatin 3 Capecitabine 3 Nivolumab 2 Neoadjuvant Therapy 2 Immunohistochemistry 2 Biopsy 2 10-propargyl-10-deazaaminopterin 2 tremelimumab 1 sitravatinib 1 sintilimab 1 regorafenib 1 pegylated granulocyte colony-stimulating factor, human 1 pegfilgrastim 1 oblimersen 1 durvalumab 1 cixutumumab 1 adavosertib 1 Taxes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡